Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
Nodes: 2913, Authors: 7350, Journals: 871, Outer References: 80285, Words: 5113
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
View: Overview | Sorted by number of publications (Pubs). |
# | Word | Pubs | TLCS | TGCS |
---|---|---|---|---|
1 | TUBERCULOSIS | 356 | 1569 | 5642 |
2 | PATIENTS | 176 | 711 | 6268 |
3 | MYCOBACTERIUM | 159 | 567 | 2999 |
4 | BCG | 153 | 1073 | 2705 |
5 | AIDS | 152 | 393 | 2155 |
6 | HEALTH | 151 | 615 | 3621 |
7 | CLINICAL | 146 | 508 | 4442 |
8 | HIV | 144 | 228 | 2233 |
9 | VACCINATION | 129 | 474 | 1856 |
10 | EVALUATION | 119 | 351 | 2017 |
11 | MEDICAL | 118 | 516 | 3018 |
12 | DISEASE | 112 | 152 | 2235 |
13 | VACCINE | 108 | 860 | 1765 |
14 | RISK | 102 | 224 | 1978 |
15 | USE | 100 | 150 | 2382 |
16 | INFECTION | 98 | 210 | 1507 |
17 | TREATMENT | 97 | 155 | 1810 |
18 | NEW | 93 | 178 | 1718 |
19 | COST-EFFECTIVENESS | 91 | 524 | 3602 |
20 | ANALYSIS | 90 | 221 | 2174 |
21 | ACUTE | 89 | 489 | 4060 |
22 | PREVENTION | 86 | 772 | 1870 |
23 | VACCINES | 83 | 310 | 1207 |
24 | CARE | 80 | 333 | 1480 |
25 | DIAGNOSTIC | 71 | 300 | 1802 |
26 | IMPACT | 71 | 190 | 1348 |
27 | BOVIS | 70 | 262 | 1445 |
28 | EFFICACY | 68 | 1145 | 2528 |
29 | TESTING | 68 | 106 | 1624 |
30 | RESEARCH | 67 | 117 | 3429 |
# | Word | Pubs | TLCS | TGCS |
31 | TECHNOLOGY | 66 | 213 | 1699 |
32 | XENOTRANSPLANTATION | 65 | 155 | 494 |
33 | ASSESSMENT | 62 | 323 | 1149 |
34 | CALMETTE-GUERIN | 62 | 327 | 1228 |
35 | PAIN | 60 | 195 | 2139 |
36 | CHEST | 57 | 233 | 2103 |
37 | HUMAN | 55 | 200 | 1348 |
38 | REVIEW | 54 | 216 | 3428 |
39 | EFFECT | 53 | 313 | 1293 |
40 | MYOCARDIAL-INFARCTION | 53 | 526 | 3435 |
41 | CHILDREN | 52 | 71 | 686 |
42 | CONTROL | 52 | 112 | 741 |
43 | IMAGING | 52 | 101 | 699 |
44 | THERAPY | 52 | 121 | 1809 |
45 | QUALITY | 51 | 95 | 1093 |
46 | PEPTIC-ULCER | 50 | 266 | 992 |
47 | COST | 49 | 177 | 1181 |
48 | USING | 49 | 121 | 1763 |
49 | SCREENING | 48 | 165 | 888 |
50 | IMPLICATIONS | 47 | 300 | 1684 |
51 | ROLE | 47 | 63 | 658 |
52 | UTILITY | 47 | 115 | 658 |
53 | MANAGEMENT | 46 | 60 | 753 |
54 | COMPUTED-TOMOGRAPHY | 45 | 91 | 762 |
55 | RESPONSES | 45 | 168 | 757 |
56 | COMPARISON | 44 | 320 | 1073 |
57 | DIAGNOSIS | 44 | 54 | 614 |
58 | IMMUNE | 43 | 118 | 761 |
59 | RESULTS | 43 | 96 | 1451 |
60 | PATIENT | 42 | 55 | 899 |
# | Word | Pubs | TLCS | TGCS |
61 | EFFECTS | 40 | 63 | 690 |
62 | HEALTH-CARE | 40 | 69 | 922 |
63 | STRATEGIES | 40 | 150 | 978 |
64 | MEDICINE | 39 | 71 | 1161 |
65 | METHODS | 39 | 452 | 2056 |
66 | TIME | 39 | 157 | 985 |
67 | TRIAL | 39 | 100 | 1813 |
68 | BACILLE | 38 | 201 | 705 |
69 | CANCER | 38 | 15 | 507 |
70 | HOSPITAL | 38 | 74 | 899 |
71 | META-ANALYSIS | 38 | 67 | 1531 |
72 | BACILLUS | 37 | 164 | 763 |
73 | ISSUES | 37 | 47 | 715 |
74 | MODEL | 37 | 148 | 625 |
75 | PHYSICIANS | 37 | 80 | 1641 |
76 | PRACTICE | 37 | 56 | 1550 |
77 | TEST | 37 | 71 | 706 |
78 | PROTECTIVE | 36 | 273 | 910 |
79 | PUBLIC | 36 | 33 | 267 |
80 | TOMOGRAPHY | 36 | 415 | 855 |
81 | TRIALS | 36 | 66 | 2417 |
82 | DECISION | 35 | 64 | 331 |
83 | DISEASES | 35 | 27 | 466 |
84 | IMMUNIZATION | 34 | 71 | 552 |
85 | LIFE | 34 | 90 | 1280 |
86 | CELL | 33 | 79 | 636 |
87 | CELLS | 33 | 96 | 676 |
88 | EMERGENCY | 33 | 192 | 2046 |
89 | LABORATORY | 33 | 63 | 829 |
90 | POLICY | 33 | 43 | 392 |
# | Word | Pubs | TLCS | TGCS |
91 | RECOMBINANT | 33 | 132 | 575 |
92 | EVIDENCE | 32 | 43 | 794 |
93 | PLANNING | 32 | 125 | 457 |
94 | ANTIGEN | 31 | 119 | 616 |
95 | COMPUTED | 31 | 288 | 720 |
96 | MYCOBACTERIAL | 31 | 69 | 442 |
97 | PERTUSSIS | 31 | 112 | 410 |
98 | PROTECTION | 31 | 157 | 570 |
99 | VALUE | 31 | 140 | 549 |
100 | CARDIAC | 30 | 65 | 1399 |
101 | CASE | 30 | 158 | 604 |
102 | DIARRHEA | 30 | 62 | 455 |
103 | ECONOMIC | 30 | 129 | 2009 |
104 | LITERATURE | 30 | 712 | 2266 |
105 | MICE | 30 | 69 | 392 |
106 | OUTCOMES | 30 | 275 | 819 |
107 | PROTEIN | 30 | 94 | 405 |
108 | SURGERY | 30 | 41 | 469 |
109 | VIRUS | 30 | 70 | 543 |
110 | CURRENT | 29 | 58 | 830 |
111 | DEVELOPMENT | 29 | 51 | 467 |
112 | INFECTIOUS | 29 | 44 | 431 |
113 | TESTS | 29 | 93 | 503 |
114 | DRUG | 28 | 11 | 387 |
115 | INFORMATION | 28 | 17 | 224 |
116 | RANDOMIZED | 27 | 94 | 2539 |
117 | STATES | 27 | 53 | 420 |
118 | TRANSMISSION | 27 | 28 | 411 |
119 | UNIT | 27 | 131 | 713 |
120 | CHILDHOOD | 26 | 35 | 235 |
# | Word | Pubs | TLCS | TGCS |
121 | COSTS | 26 | 147 | 663 |
122 | EARLY | 26 | 43 | 853 |
123 | EPIDEMIC | 26 | 53 | 365 |
124 | FUTURE | 26 | 26 | 318 |
125 | TECHNOLOGIES | 26 | 58 | 582 |
126 | APPROACH | 25 | 39 | 592 |
127 | DECISION-MAKING | 25 | 21 | 363 |
128 | DECISIONS | 25 | 40 | 891 |
129 | DNA | 25 | 145 | 650 |
130 | GUIDELINES | 25 | 81 | 1816 |
131 | KNOWLEDGE | 25 | 35 | 242 |
132 | MORTALITY | 25 | 43 | 478 |
133 | PREFERENCES | 25 | 311 | 1175 |
134 | PULMONARY | 25 | 47 | 267 |
135 | RESPONSE | 25 | 40 | 412 |
136 | WOMEN | 25 | 52 | 478 |
137 | GLOBAL | 24 | 67 | 253 |
138 | IMMUNODEFICIENCY | 24 | 60 | 553 |
139 | TECHNOLOGY-ASSESSMENT | 24 | 146 | 306 |
140 | TRENDS | 24 | 197 | 723 |
141 | TUBERCULIN | 24 | 48 | 190 |
142 | BEHAVIOR | 23 | 82 | 1066 |
143 | EVALUATING | 23 | 59 | 481 |
144 | EXPERIENCE | 23 | 38 | 396 |
145 | IMMUNITY | 23 | 274 | 1033 |
146 | METAANALYSIS | 23 | 557 | 2180 |
147 | NOVEL | 23 | 60 | 311 |
148 | PRIMARY | 23 | 42 | 652 |
149 | REPLY | 23 | 3 | 9 |
150 | REPORT | 23 | 163 | 894 |
# | Word | Pubs | TLCS | TGCS |
151 | RUBELLA | 23 | 149 | 565 |
152 | ULCER | 23 | 18 | 396 |
153 | UTILIZATION | 23 | 63 | 1249 |
154 | INFLUENCE | 22 | 82 | 511 |
155 | NATIONAL | 22 | 42 | 477 |
156 | STATE | 22 | 115 | 1367 |
157 | UTILITIES | 22 | 215 | 1688 |
158 | CORONARY | 21 | 81 | 440 |
159 | EFFECTIVENESS | 21 | 51 | 556 |
160 | EPIDEMIOLOGY | 21 | 16 | 380 |
161 | GENERAL | 21 | 39 | 388 |
162 | INCIDENCE | 21 | 29 | 426 |
163 | INTERVENTION | 21 | 21 | 536 |
164 | POTENTIAL | 21 | 37 | 375 |
165 | SURVEY | 21 | 32 | 334 |
166 | SUSPECTED | 21 | 35 | 345 |
167 | ATTITUDES | 20 | 10 | 229 |
168 | CONTROLLED | 20 | 83 | 2030 |
169 | EDUCATION | 20 | 177 | 423 |
170 | MEASURING | 20 | 92 | 633 |
171 | POPULATION | 20 | 39 | 354 |
172 | PREMARITAL | 20 | 138 | 199 |
173 | PROGRAM | 20 | 35 | 571 |
174 | SYSTEM | 20 | 23 | 367 |
175 | TRANSPLANTATION | 20 | 12 | 444 |
176 | YEARS | 20 | 69 | 398 |
177 | ADMISSION | 19 | 205 | 502 |
178 | ANTIGENS | 19 | 58 | 304 |
179 | BASED | 19 | 29 | 490 |
180 | INTRODUCTION | 19 | 153 | 663 |
# | Word | Pubs | TLCS | TGCS |
181 | MEASUREMENT | 19 | 167 | 1409 |
182 | MEASURES | 19 | 60 | 425 |
183 | MONITORING | 19 | 17 | 298 |
184 | SCIENCE | 19 | 20 | 354 |
185 | THERAPEUTIC | 19 | 150 | 434 |
186 | ADULTS | 18 | 45 | 415 |
187 | ASSESSING | 18 | 23 | 189 |
188 | ASSOCIATED | 18 | 44 | 187 |
189 | CHRONIC | 18 | 67 | 480 |
190 | CIMETIDINE | 18 | 165 | 334 |
191 | HUMAN-IMMUNODEFICIENCY-VIRUS | 18 | 121 | 356 |
192 | MYOCARDIAL | 18 | 18 | 344 |
193 | NEED | 18 | 46 | 422 |
194 | PRACTICES | 18 | 118 | 819 |
195 | PROBLEMS | 18 | 24 | 172 |
196 | RADIOTHERAPY | 18 | 16 | 208 |
197 | SAFETY | 18 | 24 | 170 |
198 | SCANNING | 18 | 122 | 280 |
199 | STATUS | 18 | 41 | 464 |
200 | UNITED-STATES | 18 | 231 | 834 |
Page 1 of 26: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21